Risk Factors for the Development of BK Polyomavirus and Treatment Outcomes in Kidney Transplant Recipients: An 8‐Year Retrospective Cohort Study
Nephrology · 2025-06 · 30 (6)
DOI: 10.1111/nep.70058 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nephrology, online erschienen am 03.06.2025. Verfasst von Alyssa Pradhan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Kidney Transplantation, Polyomavirus Infections, BK Virus, Tumor Virus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
BKPyV‐DNAemia occurs in up to 30% of kidney transplant recipients (KTRs), with graft‐threatening BKPyV‐nephropathy in up to 10%. Risk factors for BKPyV‐DNAemia, BKPyV‐nephropathy, and associated graft loss are incompletely described. We sought to determine the prevalence, risk factors for, and long‐term impact of BKPyV‐DNAemia.
Methods
A single‐centre retrospective study of adult KTRs between 2010 and 2018. We used logistic regression to determine odds ratios (OR) of BKPyV‐DNAemia, and survival analysis to assess the impact of BKPyV‐DNAemia on graft and patient survival.
Results
Of 522 patients, 100 (19%) developed BKPyV‐DNAemia and 43 (8.2%) developed BKPyV‐nephropathy, resulting in the loss of two grafts. Factors associated with the development of BKPyV‐DNAemia were non‐Caucasian ethnicity (OR 1.76, CI 0.98–3.16), pre‐transplant diabetes (OR 2.06, CI 1.02–4.14) and HLA mismatch of 3/6 or 4/6 (OR 2.37, CI 1.06–5.56) and HLA mismatch of 5/6 and 6/6 (OR 2.53, CI 1.20–5.63). Additionally, a greater than 25 mg per day prednisolone dose following acute transplant and acute rejection in the first month post‐transplant was associated with an increased risk of BKPyV‐DNAemia (OR 3.06, CI 1.66–6.06 and OR 2.36, CI 1.16–4.75 respectively). Over a 10‐year follow‐up, the development of BKPyV‐DNAemia and BKPyV‐nephropathy was not associated with reduced graft or patient survival.
Conclusion
While BKPyV‐DNAemia and BKPyV‐nephropathy remain prevalent in KTR, there were low rates of associated graft loss and no demonstrable impact on long‐term graft or patient survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Department of Infectious Diseases, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia.
- Department of Renal and Transplant Medicine, Westmead Hospital, Sydney, New South Wales, Australia.
- Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Melanie Wyld
Zitieren
APA
Pradhan, A., Wyld, M., Wan, S., Davis, R., Jayasinghe, K., & Wyburn, K. (2025). Risk Factors for the Development of BK Polyomavirus and Treatment Outcomes in Kidney Transplant Recipients: An 8‐Year Retrospective Cohort Study. Nephrology, 30(6). https://doi.org/10.1111/nep.70058
Vancouver
Pradhan A, Wyld M, Wan S, Davis R, Jayasinghe K, Wyburn K. Risk Factors for the Development of BK Polyomavirus and Treatment Outcomes in Kidney Transplant Recipients: An 8‐Year Retrospective Cohort Study. Nephrology. 2025;30(6). doi:10.1111/nep.70058
BibTeX
@article{Pradhan2025,
author = {Pradhan, Alyssa and Wyld, Melanie and Wan, Susan and Davis, Rebecca and Jayasinghe, Kushani and Wyburn, Kate},
title = {Risk Factors for the Development of BK Polyomavirus and Treatment Outcomes in Kidney Transplant Recipients: An 8‐Year Retrospective Cohort Study},
journal = {Nephrology},
year = {2025},
volume = {30},
number = {6},
doi = {10.1111/nep.70058}
}
EUVIMED